Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism

Secondary hyperparathyroidism (s-HPT) in uremia is characterized by decreased expression in the parathyroids of calcium sensing (CaR) and vitamin D receptors (VDR). Parathyroid hormone (PTH) is normalized despite low levels of CaR and VDR after experimental reversal of uremia. The expression of CaR...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacob Hofman-Bang, Eva Gravesen, Klaus Olgaard, Ewa Lewin
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2012/123576
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554585768591360
author Jacob Hofman-Bang
Eva Gravesen
Klaus Olgaard
Ewa Lewin
author_facet Jacob Hofman-Bang
Eva Gravesen
Klaus Olgaard
Ewa Lewin
author_sort Jacob Hofman-Bang
collection DOAJ
description Secondary hyperparathyroidism (s-HPT) in uremia is characterized by decreased expression in the parathyroids of calcium sensing (CaR) and vitamin D receptors (VDR). Parathyroid hormone (PTH) is normalized despite low levels of CaR and VDR after experimental reversal of uremia. The expression of CaR in parathyroid cultures decreases rapidly. Methylation of promoter regions is often detected during epigenetic downregulation of gene expression. Therefore, using an experimental rat model, we examined changes in methylation levels of parathyroid CaR and VDR promoters in vivo and in vitro. Methods. Uremia was induced by 5/6 nephrectomy. Melting temperature profiling of CaR and VDR PCR products after bisulfite treatment of genomic DNA from rat parathyroids was performed. Real-time PCR measured expression of PTH, CaR, VDR, and klotho genes in vitro. Results. Parathyroids from uremic rats had similar low levels of methylation in vivo and in vitro. In culture, a significant downregulation of CaR, VDR, and klotho within two hours of incubation was observed, while housekeeping genes remained stable for 24 hours. Conclusion. In uremic s-HPT and in vitro, no overall changes in methylation levels in the promoter regions of parathyroid CaR and VDR genes were found. Thus, epigenetic methylation of these promoters does not explain decreased parathyroid expression of CaR and VDR genes in uremic s-HPT.
format Article
id doaj-art-a825ec98176b4e5d8c21f61ffd9b1772
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-a825ec98176b4e5d8c21f61ffd9b17722025-02-03T05:51:06ZengWileyInternational Journal of Nephrology2090-214X2090-21582012-01-01201210.1155/2012/123576123576Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary HyperparathyroidismJacob Hofman-Bang0Eva Gravesen1Klaus Olgaard2Ewa Lewin3Nephrological Department P2132, Rigshospitalet, Herlev Hospital, University of Copenhagen, 9 Blegdamsvej, 2100 Copenhagen, DenmarkNephrological Department P2132, Rigshospitalet, Herlev Hospital, University of Copenhagen, 9 Blegdamsvej, 2100 Copenhagen, DenmarkNephrological Department P2132, Rigshospitalet, Herlev Hospital, University of Copenhagen, 9 Blegdamsvej, 2100 Copenhagen, DenmarkNephrological Department P2132, Rigshospitalet, Herlev Hospital, University of Copenhagen, 9 Blegdamsvej, 2100 Copenhagen, DenmarkSecondary hyperparathyroidism (s-HPT) in uremia is characterized by decreased expression in the parathyroids of calcium sensing (CaR) and vitamin D receptors (VDR). Parathyroid hormone (PTH) is normalized despite low levels of CaR and VDR after experimental reversal of uremia. The expression of CaR in parathyroid cultures decreases rapidly. Methylation of promoter regions is often detected during epigenetic downregulation of gene expression. Therefore, using an experimental rat model, we examined changes in methylation levels of parathyroid CaR and VDR promoters in vivo and in vitro. Methods. Uremia was induced by 5/6 nephrectomy. Melting temperature profiling of CaR and VDR PCR products after bisulfite treatment of genomic DNA from rat parathyroids was performed. Real-time PCR measured expression of PTH, CaR, VDR, and klotho genes in vitro. Results. Parathyroids from uremic rats had similar low levels of methylation in vivo and in vitro. In culture, a significant downregulation of CaR, VDR, and klotho within two hours of incubation was observed, while housekeeping genes remained stable for 24 hours. Conclusion. In uremic s-HPT and in vitro, no overall changes in methylation levels in the promoter regions of parathyroid CaR and VDR genes were found. Thus, epigenetic methylation of these promoters does not explain decreased parathyroid expression of CaR and VDR genes in uremic s-HPT.http://dx.doi.org/10.1155/2012/123576
spellingShingle Jacob Hofman-Bang
Eva Gravesen
Klaus Olgaard
Ewa Lewin
Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
International Journal of Nephrology
title Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
title_full Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
title_fullStr Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
title_full_unstemmed Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
title_short Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
title_sort epigenetic methylation of parathyroid car and vdr promoters in experimental secondary hyperparathyroidism
url http://dx.doi.org/10.1155/2012/123576
work_keys_str_mv AT jacobhofmanbang epigeneticmethylationofparathyroidcarandvdrpromotersinexperimentalsecondaryhyperparathyroidism
AT evagravesen epigeneticmethylationofparathyroidcarandvdrpromotersinexperimentalsecondaryhyperparathyroidism
AT klausolgaard epigeneticmethylationofparathyroidcarandvdrpromotersinexperimentalsecondaryhyperparathyroidism
AT ewalewin epigeneticmethylationofparathyroidcarandvdrpromotersinexperimentalsecondaryhyperparathyroidism